Test strips market seen reaching $85.21 billion by 2030

The test strips market reached $68.13 billion in 2025 and is projected to hit $71.42 billion in 2026, driven by diabetes growth, home testing demand and digital diagnostics. The Business Research Company said North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Test strips are becoming more important as healthcare shifts toward early detection, home monitoring and point-of-care testing. - The market’s growth reflects rising demand for faster, more convenient diagnostic tools across consumer and clinical settings. - Diabetes prevalence is a major demand driver because blood glucose monitoring relies on frequent strip-based testing.

What happened: - The Business Research Company released its Test Strips Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report said the global test strips market was worth $68.13 billion in 2025. - The market is projected to rise to $71.42 billion in 2026. - The report forecasts the market will reach $85.21 billion by 2030. - The report estimated a 4.8% CAGR for the 2025-to-2026 period and a 4.5% CAGR through 2030. - North America was the largest regional market in 2025. - Asia-Pacific is forecast to be the fastest-growing region in the coming years.

The details: - Test strips are single-use devices coated with chemical reagents that react to substances in liquids such as blood or urine. - Test strips provide quick measurement of analytes for health monitoring and contamination detection. - The report linked past growth to limited access to home-testing kits, reliance on conventional laboratory diagnostics, rising diabetes rates, greater awareness of early disease screening and restricted distribution channels. - Future growth is expected to come from biosensor advances, wider use of digital health platforms, growth in hospital and homecare services and integration of AI-powered diagnostic tools. - The report highlighted growth in home-based testing, demand for multi-parameter strips, mobile app compatibility, point-of-care diagnostics and faster, more accurate detection. - The regional analysis covered Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The Business Research Company made a free sample report available here. - The full report is available here.

Between the lines: - The report points to a market moving beyond basic reagent strips toward connected and AI-enabled diagnostics. - Home testing and digital health compatibility appear to be turning test strips from a commodity product into part of broader care workflows. - The strong diabetes link suggests demand may stay resilient even if broader diagnostics spending slows.

What's next: - The report expects AI-powered tools, biosensors and digital platforms to shape the next phase of market growth. - Asia-Pacific’s faster growth could shift more commercial attention toward emerging healthcare markets. - Hospitals, homecare providers and consumer health brands are likely to keep expanding use cases for test strips.

The bottom line: - Test strips remain a growing global diagnostics market, with diabetes care and at-home testing powering the next wave of expansion.